Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia
Authors:
- 26 February 2010
- journal article
- review article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 23 (1) , 25-32
Abstract
Ventilator-associated pneumonia (VAP) is one of the most common causes of infection in intensive care unit (ICU) patients. Efforts to prevent VAP have focused on both pharmacologic and nonpharmacologic strategies. Two of the more controversial pharmacologic approaches included selective decontamination of the digestive tract (SDD) and decontamination of the oropharynx using topical antimicrobials or antiseptics including chlorhexidine (CHX). Additionally, avoidance of pharmacotherapy-related risk factors is hypothesized to reduce VAP rates. Successful treatment of VAP is becoming increasingly difficult in the era of antibiotic resistance. Utilization of local antibiograms, implementation of standardized treatment pathways, and optimization of pharmacodynamic-based dosing offer methods to improve empiric therapy selections. De-escalation of therapy should be a constant focus in an attempt to reduce overall antibiotic consumption and the selection pressure on ICU flora, thus minimizing the development and spread of antimicrobial resistance in the ICU.Keywords
This publication has 57 references indexed in Scilit:
- Impact of Selective Decontamination of the Digestive Tract on Carriage and Infection Due to Gram-Negative and Gram-Positive Bacteria: A Systematic Review of Randomised Controlled TrialsAnaesthesia and Intensive Care, 2008
- Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysisBMJ, 2007
- Survival Benefit in Critically Ill Burned Patients Receiving Selective Decontamination of the Digestive TractAnnals of Surgery, 2005
- Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trialThe Lancet, 2003
- Influence of Combined Intravenous and Topical Antibiotic Prophylaxis on the Incidence of Infections, Organ Dysfunctions, and Mortality in Critically Ill Surgical Patients: A Prospective, Stratified, Randomized, Double-Blind, Placebo-controlled Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Relationship Between Methodological Trial Quality and the Effects of Selective Digestive Decontamination on Pneumonia and Mortality in Critically Ill PatientsJAMA, 2001
- Changing bacterial ecology during a five year period of selective intestinal decontaminationJournal of Hospital Infection, 1998
- Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unitCritical Care Medicine, 1997
- Double-blind study of selective decontamination of the digestive tract in intensive careThe Lancet, 1992
- The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patientsIntensive Care Medicine, 1984